Den centraliserede procedure er obligatorisk for bioteknologisk fremstillede lægemidler og kan anvendes for andre innovative produkter efter virksomhedens anmodning.
The centralised procedure is compulsory for medicinal products derived from biotechnology, and available at the request of companies for other innovative new products.